Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion type Assertion NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_head.
- NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion description "[Moreover, the tumor-to-normal ratio of MDM4 levels for each individual was significantly lower in late tumor stages, suggesting a specific downregulation of MDM4 expression with tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_provenance.
- NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion evidence source_evidence_literature NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_provenance.
- NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion SIO_000772 18335186 NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_provenance.
- NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion wasDerivedFrom befree-20150227 NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_provenance.
- NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_assertion wasGeneratedBy ECO_0000203 NP551596.RAvieG4FtUQvpVlTLpZPrNYevw9wvehKQKmPIDyEgYrz0130_provenance.